AVEO Oncology
AVEO
#7323
Rank
โ‚น48.32 B
Marketcap
โ‚น1,390
Share price
0.00%
Change (1 day)
182.90%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -โ‚น2.24 Billion

According to AVEO Oncology 's latest financial reports the company's current earnings are โ‚น94.31 Million. In 2021 the company made an earning of -โ‚น4.95 Billion a decrease over its 2020 earnings that were of -โ‚น3.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -โ‚น2.24 Billion-54.75%
2021 -โ‚น4.95 Billion49.9%
2020 -โ‚น3.3 Billion-479.04%
2019 โ‚น0.86 B-276.17%
2018 -โ‚น0.5 Billion-91.79%
2017 -โ‚น6.02 Billion142.38%
2016 -โ‚น2.49 Billion78.51%
2015 -โ‚น1.4 Billion-71.55%
2014 -โ‚น4.89 Billion-50.72%
2013 -โ‚น9.92 Billion-4.88%
2012 -โ‚น10.43 Billion-426.29%
2011 โ‚น3.19 B-159.85%
2010 -โ‚น5.34 Billion35.33%
2009 -โ‚น3.95 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚น3.222 T-119,832.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1.024 T-38,159.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น41.24 B-1,632.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น526.99 B-19,683.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.050 T-39,123.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-โ‚น0.21 Billion-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA